Physician profile
Wesley Jackson
NPI 1285085357
$5,895.89
in general payments reported to CMS, 2019-2025
21 companies · $1,386 in 2025
The $1,386 reported for 2025 was more than what 76% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $706 · 2020: $267 · 2021: $445 · 2022: $753 · 2023: $435 · 2024: $1,904 · 2025: $1,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,310 · Travel and Lodging: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,310.19 |
| Travel and Lodging | $1,414.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,733.08 | 2019-2025 | Actishield, Augment Injectable, Citrefix |
| Team 1, LLC | $1,567.82 | 2023-2024 | |
| Organogenesis INC. | $831.06 | 2019-2025 | Affinity, Novachor, Nushield |
| Smith+Nephew, INC. | $328.85 | 2019-2025 | Grafix Pl, Stravix |
| Arthrex, INC. | $268.31 | 2024-2025 | |
| Biotissue Holdings INC. | $254.14 | 2023-2024 | |
| Horizon Therapeutics Plc | $213.52 | 2022 | |
| Coastal Medical Technologies LLC | $175.25 | 2025 | |
| Liberty Surgical INC. | $99.46 | 2019 | |
| Amniox Medical, INC. | $93.75 | 2019 | |
| Triad Life Sciences INC. | $93.09 | 2022 | |
| Integra Lifesciences Corporation | $49.81 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $27.97 | 2023 | Intellis Adaptivestim |
| Peerless Surgical INC. | $27.84 | 2021 | |
| Linvatec Corporation | $25.95 | 2025 | Fracture and Correction Colag 2, Biobrace 23mm |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $21.23 | 2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $19.13 | 2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $18.97 | 2023 | Nuzyra |
| Amgen INC. | $16.62 | 2025 | Krystexxa |
| Kerecis Limited | $15.16 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Royal Biologics, INC. | $14.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.